🇺🇸 FDA
Patent

US 7510715

Protozoan derived compositions and methods of use thereof

granted A61KA61K38/16A61K39/002

Quick answer

US patent 7510715 (Protozoan derived compositions and methods of use thereof) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon Mar 26 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as Represented by the Secretary of the Department of Health and Human Services
Grant date
Tue Mar 31 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 26 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61K, A61K38/16, A61K39/002